285 related articles for article (PubMed ID: 12020054)
1. Ximelagatran (AstraZeneca).
Hopfner R
Curr Opin Investig Drugs; 2002 Feb; 3(2):246-51. PubMed ID: 12020054
[TBL] [Abstract][Full Text] [Related]
2. Valdecoxib (Pharmacia).
Gotta AW
Curr Opin Investig Drugs; 2002 Feb; 3(2):240-5. PubMed ID: 12020053
[TBL] [Abstract][Full Text] [Related]
3. Exubera. Inhale therapeutic systems.
Bindra S; Cefalu WT
Curr Opin Investig Drugs; 2002 May; 3(5):758-62. PubMed ID: 12090549
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitor.
Halperin JL
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):163-74. PubMed ID: 15151465
[TBL] [Abstract][Full Text] [Related]
5. Etanercept Immunex.
Yung RL
Curr Opin Investig Drugs; 2001 Feb; 2(2):216-21. PubMed ID: 11816834
[TBL] [Abstract][Full Text] [Related]
6. Cariporide Aventis.
Chin B; Lip GY
Curr Opin Investig Drugs; 2000 Nov; 1(3):340-6. PubMed ID: 11249717
[TBL] [Abstract][Full Text] [Related]
7. Etanercept. Immunex.
Pugsley MK
Curr Opin Investig Drugs; 2001 Dec; 2(12):1725-31. PubMed ID: 11892935
[TBL] [Abstract][Full Text] [Related]
8. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
9. ZD-1839 (AstraZeneca).
Norman P
Curr Opin Investig Drugs; 2001 Mar; 2(3):428-34. PubMed ID: 11575718
[TBL] [Abstract][Full Text] [Related]
10. SR-90107 (Sanofi-Synthélabo).
Liu F; Bagley WP; Carroll RC
IDrugs; 2000 Sep; 3(9):1088-99. PubMed ID: 16049869
[TBL] [Abstract][Full Text] [Related]
11. Ximelagatran: an orally active direct thrombin inhibitor.
Gulseth MP
Am J Health Syst Pharm; 2005 Jul; 62(14):1451-67. PubMed ID: 15998925
[TBL] [Abstract][Full Text] [Related]
12. Ximelagatran: a new oral anticoagulant.
Hrebickova L; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322
[TBL] [Abstract][Full Text] [Related]
13. Ximelagatran/Melagatran: a review of its use in the prevention of venous thromboembolism in orthopaedic surgery.
Evans HC; Perry CM; Faulds D
Drugs; 2004; 64(6):649-78. PubMed ID: 15018597
[TBL] [Abstract][Full Text] [Related]
14. Ximelagatran: an oral direct thrombin inhibitor.
Dager WE; Vondracek TG; McIntosh BA; Nutescu EA
Ann Pharmacother; 2004 Nov; 38(11):1881-97. PubMed ID: 15383641
[TBL] [Abstract][Full Text] [Related]
15. Tomoxetine (Eli Lilly & Co).
Preti A
Curr Opin Investig Drugs; 2002 Feb; 3(2):272-7. PubMed ID: 12020059
[TBL] [Abstract][Full Text] [Related]
16. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
Prescrire Int; 2005 Aug; 14(78):127-32. PubMed ID: 16106594
[TBL] [Abstract][Full Text] [Related]
17. Telithromycin. Aventis Pharma.
Johnson AP
Curr Opin Investig Drugs; 2001 Dec; 2(12):1691-701. PubMed ID: 11892930
[TBL] [Abstract][Full Text] [Related]
18. Pexelizumab Alexion.
Whiss PA
Curr Opin Investig Drugs; 2002 Jun; 3(6):870-7. PubMed ID: 12137406
[TBL] [Abstract][Full Text] [Related]
19. Fosamprenavir. Vertex Pharmaceuticals/GlaxoSmithKline.
Corbett AH; Kashuba AD
Curr Opin Investig Drugs; 2002 Mar; 3(3):384-90. PubMed ID: 12054084
[TBL] [Abstract][Full Text] [Related]
20. Dalbavancin (Biosearch Italia/Versicor).
Steiert M; Schmitz FJ
Curr Opin Investig Drugs; 2002 Feb; 3(2):229-33. PubMed ID: 12020051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
